Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Italian Journal of Pediatrics
Published in: Italian Journal of Pediatrics 1/2011

Open Access 01-12-2011 | Research

Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study

Authors: Mohammed Sanad, Mohammed Osman, Amal Gharib

Published in: Italian Journal of Pediatrics | Issue 1/2011

Login to get access

Abstract

Background

Recently, hepcidin expression in adipose tissue has been described and shown to be increased in patients with severe obesity. We tried to assess the effect of obesity on hepcidin serum levels and treatment outcome of iron deficiency anemia in children.

Methods

This was a case control study included 70 children with iron deficiency anemia "IDA" (35 obese and 35 non-obese) and 30 healthy non-obese children with comparable age and sex(control group). Parameters of iron status (Serum iron, ferritin, transferrin, total iron binding capacity and transferrin saturation) and serum hepcidin levels were assessed initially and after 3 months of oral iron therapy for IDA.

Results

Compared to the control group, serum hepcidin was significantly lower in non-obese children with IDA(p < 0.01) and significantly higher in obese children with IDA (p < 0.01). Hepcidin increased significantly in non-obese children with IDA after 3 months of iron therapy (P < 0.01). On the other hand, obese children showed non-significant change in hepcidin level after iron therapy (p > 0.05). Although hepcidin showed significant positive correlations with Hb, serum iron and transferrin saturation in non-obese children with IDA, it showed significant negative correlations with Hb, serum iron and transferrin saturation in obese children with IDA (P < 0.05).

Conclusions

Obesity increased hepcidin levels and was associated with diminished response to oral iron therapy in childhood iron deficiency anemia.
Appendix
Available only for authorised users
Literature
1.
2.
Seltzer CC, Mayer J: Serum iron and iron-binding capacity in adolescents: Comparison of obese and non-obese subjects. Am J Clin Nutr. 1963, 13: 354-61.PubMed
3.
Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004, 114: 104-8. 10.1542/peds.114.1.104.CrossRefPubMed
4.
Whitfield JB, Treloar S, Zhu G, Powell LW, Martin NG: Relative importance of female-specific and non female-specific effects on variation in iron stores between women. Br J Haematol. 2003, 120: 860-66. 10.1046/j.1365-2141.2003.04224.x.CrossRefPubMed
5.
Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J: Iron deficiency in obese postmenopausal women. Obesity (Silver Spring). 2006, 14: 1724-30. 10.1038/oby.2006.198.CrossRef
6.
Failla ML, Kennedy ML, Chen ML: Iron metabolism in genetically obese (ob/ob) mice. J Nutr. 1988, 118: 46-51.PubMed
7.
Menzie CM, Yanoff LB, Denkinger BI, Mchugh T, Sebring NG, Calis KA, Yanovski JA: Obesity related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc. 2008, 108: 145-48. 10.1016/j.jada.2007.10.034.PubMedCentralCrossRefPubMed
8.
Haluzik M, Parizkova J, Haluzik MM: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res. 2004, 3: 123-29.
9.
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006, 131: 788-96. 10.1053/j.gastro.2006.07.007.CrossRefPubMed
10.
Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D: Novel urine hepcidin assay by mass spectrometry. Blood. 2005, 106 (9): 3268-70. 10.1182/blood-2005-05-1873.CrossRefPubMed
11.
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001, 276: 7811-19. 10.1074/jbc.M008923200.CrossRefPubMed
12.
Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002, 99: 4596-601. 10.1073/pnas.072632499.PubMedCentralCrossRefPubMed
13.
Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25: 4-7. 10.1016/j.it.2003.10.013.CrossRefPubMed
14.
Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006, 38: 531-39. 10.1038/ng1777.CrossRefPubMed
15.
Goswami T, Andrews NC: Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem. 2006, 281: 28494-98. 10.1074/jbc.C600197200.CrossRefPubMed
16.
Weizer-Stern O, Adamsky K, Amariglio N, Levin C, Koren A, Breuer W, Rachmilewitz E, Breda L, Rivella , Cabantchik ZI, Rechavi G: Downregulation of hepcidin and haemojuvelin expression in the hepatocytes cell-line HepG2 induced by thalassaemic sera. Br J Haematol. 2006, 135: 129-38. 10.1111/j.1365-2141.2006.06258.x.CrossRefPubMed
17.
Verga Falzacappa MV, Spasic MV, Kessler R, Stolte J, Hentze MW, Muckenthaler MU: STAT-3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007, 109: 353-58. 10.1182/blood-2006-07-033969.CrossRefPubMed
18.
Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP: An Insight into the Relationships between Hepcidin, Anemia, Infections and Inflammatory Cytokines in Pediatric Refugees: A Cross-Sectional Study. PLoS ONE. 2008, 3 (12): e4030-10.1371/journal.pone.0004030.PubMedCentralCrossRefPubMed
19.
Metzgeroth G, Adelberger V, Dorn-Beineke A, Kuhn C, Schatz M, Maywald O, Bertsch T, Wisser H, Hehlmann R, Hastka J: Soluble transferrin receptor and zinc protoporphyrin--competitors or efficient partners?. Eur J Haematol. 2005, 75: 309-17. 10.1111/j.1600-0609.2005.00515.x.CrossRefPubMed
20.
Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004, 114: 104-8. 10.1542/peds.114.1.104.CrossRefPubMed
21.
Gillum RF: Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: the Third National Health and Nutrition Examination Survey. Int J Obes. 2001, 25: 639-45. 10.1038/sj.ijo.0801561.CrossRef
22.
Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I, Hurrell RF: Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes. 2008, 32: 1098-104. 10.1038/ijo.2008.43.CrossRef
23.
del Giudice EM, Santoro N, Amato A, Brienza C, Calabrò P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L: Hepcidin in Obese Children as a Potential Mediator of the Association between Obesity and Iron Deficiency. J Clin Endocrinol Metab. 2009, 94 (12): 5102-7. 10.1210/jc.2009-1361.CrossRefPubMed
24.
Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, Yanovski JA: Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond). 2007, 31 (9): 1412-19. 10.1038/sj.ijo.0803625.CrossRef
25.
Greenberg AS, Obin MS: Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006, 83: 461S-465S.PubMed
26.
27.
Rogers JT: Ferritin translation by interleukin-1 and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood. 1996, 87: 2525-37.PubMed
28.
Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M: Immunoassay for human serum hepcidin. Blood. 2008, 112 (10): 4292-97. 10.1182/blood-2008-02-139915.CrossRefPubMed
29.
Nemeth E: Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemia. Adv Hematol. 2010, 750643-2010
30.
Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003, 101: 2461-63. 10.1182/blood-2002-10-3235.CrossRefPubMed
31.
Laftah AH, Ramesh B, Simpson RJ, Solanky N, Bahram S, Schumann K, Debnam ES, Srai SK: Effect of hepcidin on intestinal iron absorption in mice. Blood. 2004, 103: 3940-44. 10.1182/blood-2003-03-0953.CrossRefPubMed
32.
Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M: Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 over expression and down-regulated by hepcidin. Proc Natl Acad Sci USA. 2005, 102: 1324-28. 10.1073/pnas.0409409102.PubMedCentralCrossRefPubMed
33.
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004, 113: 1271-76.PubMedCentralCrossRefPubMed
34.
Lin L, Goldbberg YP, Ganz T: Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood. 2005, 106: 2884-89. 10.1182/blood-2005-05-1845.CrossRefPubMed
35.
Vokurka M, Lacinova Z, Kremen J, Kopecky P, Blaha J, Pelinkova K, Haluzík M, Necas E: Hepcidin Expression in Adipose Tissue Increases during Cardiac Surgery. Physiol Res. 2010, 59: 393-400.PubMed
36.
Anty R, Dahman M, Iannelli A, Gual P, Staccini-Myx A, Amor IB, Luciani N, Saint-Paul MC, Huet PM, Sadoul JL, Srai SK, Unwin R, Gugenheim J, Le Marchand-Brustel Y, Tran A, Bekri S: Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008, 18: 709-14. 10.1007/s11695-007-9276-y.CrossRefPubMed
Metadata
Title
Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study
Authors
Mohammed Sanad
Mohammed Osman
Amal Gharib
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2011
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-37-34

Other articles of this Issue 1/2011

Italian Journal of Pediatrics 1/2011 Go to the issue

Research

Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/Creatinine activity index in children receiving antiepileptic drugs: a randomized controlled trial

Review

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future

Review

Framework conditions facilitating paediatric clinical research

Research

Tracheostomy and mechanical ventilation weaning in children affected by respiratory virus according to a weaning protocol in a pediatric intensive care unit in Argentina: an observational restrospective trial

Case report

Acute interstitial nephritis with acetaminophen and alcohol intoxication

Case report

Basal ganglia stroke due to mild head trauma in pediatric age - clinical and therapeutic management: a case report and 10 year literature review